Klinik Araştırma

EVALUATION OF NEUTROPHIL LYMPHOCYTE RATIO, PLATELET LYMPHOCYTE RATIO AND MEAN PLATELET VOLUME IN MAJOR DEPRESSIVE DISORDER

Cilt: 29 Sayı: 3 30 Eylül 2022
PDF İndir
EN TR

EVALUATION OF NEUTROPHIL LYMPHOCYTE RATIO, PLATELET LYMPHOCYTE RATIO AND MEAN PLATELET VOLUME IN MAJOR DEPRESSIVE DISORDER

Öz

Objective The relationship between chronic inflammation and psychiatric disorders has been evaluated in previous studies. Neutrophil-lymphocyte ratio (NLR), platelet- lymphocyte ratio (PLR), and mean platelet volume (MPV) appear to be new markers for the evaluation of systemic inflammatory response. In this study, it was aimed to evaluate the levels of NLR, PLR and MPV biomarkers in patients with major depressive disorder (MDD) by comparing them with healthy controls, and also investigate the relationship between biomarkers and MDD. Material and Method This cross-sectional study was carried out from July 15, 2020 to May 15, 2021. The study was conducted with 92 patients with diagnosed MDD and 72 healthy controls who agreed to participate. The sociodemographic data form and SCID-5/CV form were filled out for each participant through face-to-face interviews with all participants. Additionally, Hamilton Depression Scale was applied to the patient group to determine the severity of MDB. Results Patients with MDD and healthy controls were compared in terms of the mean scores of NLR, PLR and MPV, and no statistically significant difference was found between the groups (p>0.05). Additionally, in the patient group, there was no statistically significant difference between the levels of depression severity (mild, moderate, severe) in terms of the mean scores of NLR, PLR, and MPV (p>0.05). Conclusion This is the first study to evaluate NLR, PLR and MPV biomarkers simultaneously in MDD patients by comparing them with healthy controls. In this study, it was found that there was no significant relationship between NLR, PLR and MPV levels and MDD. Additionally, it was determined that there was no relationship between the severity of depression and the aforementioned markers. Further studies investigating these and another biomarkers with prospective and larger studies will provide more insight into the inflammatory process in MDD.

Anahtar Kelimeler

Kaynakça

  1. 1. Tuğlu C, Kara SH. Depresyon, sitokinler ve bağışıklık sistemi. Klinik Psikofarmakoloji Bülteni 2003; 13:142-150.
  2. 2. Gümrü S, Arıcıoğlu F. Inflammation in depression: the role of cytokines. Marmara Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi 2012; 2:103-107.
  3. 3. Krishnadas R, Cavanagh J. Depression: an inflammatory illness? J Neurol Neurosurg Psychiatry 2012; 83:495-502.
  4. 4. Raedler TJ. Inflammatory mechanisms in major depressive disorder. Curr Opin Psychiatry 2011; 24:519–525.
  5. 5. Sunbul M, Gerin F, Durmus E, Kivrak T, Sari I, Tigen K, et al. Neutrophil to lymphocyte and platelet to lymphocyte ratio in patients with dipper versus non-dipper hypertension. Clin Exp Hypertens 2014; 36:217-221.
  6. 6. Sunbul EA, Sunbul M, Yanartas O, Cengiz F, Bozbay M, Increased neutrophil/lymphocyte ratio in patients with depression is correlated with the severity of depression and cardiovascular risc factors. Psychiatry Investig 2016; 13(1):121-126.
  7. 7. Semiz M, Yildirim O, Canan F Elevated neutrophil/lymphocyte ratio in patients with schizophrenia. Psychiatr Danub 2014; 26(3):220-225.
  8. 8. Kuyumcu ME, Yesil Y, Oztürk ZA. The evaluation of neutrophil lymphocyte ratio in Alzheimer’s disease. Dement Geriatr Cogn Disord 2012; 34:69-74.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Klinik Tıp Bilimleri

Bölüm

Klinik Araştırma

Yayımlanma Tarihi

30 Eylül 2022

Gönderilme Tarihi

20 Temmuz 2022

Kabul Tarihi

21 Eylül 2022

Yayımlandığı Sayı

Yıl 2022 Cilt: 29 Sayı: 3

Kaynak Göster

APA
Korkut, S. (2022). EVALUATION OF NEUTROPHIL LYMPHOCYTE RATIO, PLATELET LYMPHOCYTE RATIO AND MEAN PLATELET VOLUME IN MAJOR DEPRESSIVE DISORDER. Medical Journal of Süleyman Demirel University, 29(3), 504-509. https://doi.org/10.17343/sdutfd.1146181
AMA
1.Korkut S. EVALUATION OF NEUTROPHIL LYMPHOCYTE RATIO, PLATELET LYMPHOCYTE RATIO AND MEAN PLATELET VOLUME IN MAJOR DEPRESSIVE DISORDER. SDÜ Tıp Fak Derg. 2022;29(3):504-509. doi:10.17343/sdutfd.1146181
Chicago
Korkut, Süleyman. 2022. “EVALUATION OF NEUTROPHIL LYMPHOCYTE RATIO, PLATELET LYMPHOCYTE RATIO AND MEAN PLATELET VOLUME IN MAJOR DEPRESSIVE DISORDER”. Medical Journal of Süleyman Demirel University 29 (3): 504-9. https://doi.org/10.17343/sdutfd.1146181.
EndNote
Korkut S (01 Eylül 2022) EVALUATION OF NEUTROPHIL LYMPHOCYTE RATIO, PLATELET LYMPHOCYTE RATIO AND MEAN PLATELET VOLUME IN MAJOR DEPRESSIVE DISORDER. Medical Journal of Süleyman Demirel University 29 3 504–509.
IEEE
[1]S. Korkut, “EVALUATION OF NEUTROPHIL LYMPHOCYTE RATIO, PLATELET LYMPHOCYTE RATIO AND MEAN PLATELET VOLUME IN MAJOR DEPRESSIVE DISORDER”, SDÜ Tıp Fak Derg, c. 29, sy 3, ss. 504–509, Eyl. 2022, doi: 10.17343/sdutfd.1146181.
ISNAD
Korkut, Süleyman. “EVALUATION OF NEUTROPHIL LYMPHOCYTE RATIO, PLATELET LYMPHOCYTE RATIO AND MEAN PLATELET VOLUME IN MAJOR DEPRESSIVE DISORDER”. Medical Journal of Süleyman Demirel University 29/3 (01 Eylül 2022): 504-509. https://doi.org/10.17343/sdutfd.1146181.
JAMA
1.Korkut S. EVALUATION OF NEUTROPHIL LYMPHOCYTE RATIO, PLATELET LYMPHOCYTE RATIO AND MEAN PLATELET VOLUME IN MAJOR DEPRESSIVE DISORDER. SDÜ Tıp Fak Derg. 2022;29:504–509.
MLA
Korkut, Süleyman. “EVALUATION OF NEUTROPHIL LYMPHOCYTE RATIO, PLATELET LYMPHOCYTE RATIO AND MEAN PLATELET VOLUME IN MAJOR DEPRESSIVE DISORDER”. Medical Journal of Süleyman Demirel University, c. 29, sy 3, Eylül 2022, ss. 504-9, doi:10.17343/sdutfd.1146181.
Vancouver
1.Süleyman Korkut. EVALUATION OF NEUTROPHIL LYMPHOCYTE RATIO, PLATELET LYMPHOCYTE RATIO AND MEAN PLATELET VOLUME IN MAJOR DEPRESSIVE DISORDER. SDÜ Tıp Fak Derg. 01 Eylül 2022;29(3):504-9. doi:10.17343/sdutfd.1146181

                                                                                         14791


Süleyman Demirel Üniversitesi Tıp Fakültesi Dergisi/Medical Journal of Süleyman Demirel University is licensed under Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International.